To include your compound in the COVID-19 Resource Center, submit it here.

More RPC1063 data boosts Receptos

Investors have added $364 million in market cap to Receptos Inc. (NASDAQ:RCPT) over the past two days after the biotech provided the first look at annualized relapse rates (ARRs) for RPC1063

Read the full 318 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE